Controversial protamine in dealing with acute cardiac tamponade during radiofrequency ablation

Chin Med J (Engl). 2021 Jun 30;134(20):2503-2505. doi: 10.1097/CM9.0000000000001601.

Authors

Dong-Dong Que^{1

2

3

4}, Li-Yun Feng^{1

2

3

4}, Ya-Shu Yang^{1

2

3

4}, Xu-Dong Song^{1

2

3

4}, Ping-Zhen Yang^{1

2

3

4}

Affiliations

¹ Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, China.
² Sino-Japanese Cooperation Platform for Translational Research in Heart Failure, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, China.
³ Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, China.
⁴ Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, China.

No abstract available

Publication types

Letter

MeSH terms

Atrial Fibrillation* / surgery
Cardiac Tamponade* / surgery
Catheter Ablation*
Humans
Protamines
Radiofrequency Ablation*
Treatment Outcome

Substances

Protamines